Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.8 USD | -2.90% | -5.75% | -23.92% |
Financials (USD)
Sales 2024 * | 29.54M | Sales 2025 * | 186M | Capitalization | 2.13B |
---|---|---|---|---|---|
Net income 2024 * | -262M | Net income 2025 * | -217M | EV / Sales 2024 * | 66.4 x |
Net cash position 2024 * | 163M | Net cash position 2025 * | 59.29M | EV / Sales 2025 * | 11.1 x |
P/E ratio 2024 * |
-8.83
x | P/E ratio 2025 * |
-12.5
x | Employees | 268 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.43% |
Latest transcript on Rocket Pharmaceuticals, Inc.
1 day | -0.84% | ||
1 week | -7.12% | ||
Current month | -12.84% | ||
1 month | -11.46% | ||
3 months | -10.24% | ||
6 months | +39.93% | ||
Current year | -21.65% |
Managers | Title | Age | Since |
---|---|---|---|
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 18-01-03 |
Kinnari Patel
PSD | President | 46 | 18-01-03 |
Chief Tech/Sci/R&D Officer | 60 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pedro Granadillo
BRD | Director/Board Member | 77 | 18-01-03 |
Carsten Boess
BRD | Director/Board Member | 57 | 15-12-31 |
David Southwell
BRD | Director/Board Member | 63 | 14-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.15% | 2 M€ | -.--% | ||
0.13% | 0 M€ | 0.00% | - | |
0.09% | 0 M€ | 0.00% | - | |
0.06% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 22.8 | -2.90% | 960 831 |
24-04-18 | 23.48 | -0.84% | 551,369 |
24-04-17 | 23.68 | -2.35% | 640,566 |
24-04-16 | 24.25 | +1.00% | 888,765 |
24-04-15 | 24.01 | -0.74% | 584,057 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.65% | 2.13B | |
-3.30% | 102B | |
+1.79% | 96.07B | |
-1.43% | 21.66B | |
-18.35% | 20.77B | |
-8.72% | 18.53B | |
-40.31% | 16.91B | |
-26.84% | 13.79B | |
+0.59% | 13.33B | |
+20.86% | 10.94B |
- Stock Market
- Equities
- RCKT Stock